XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
The effect of the Restatement described above on the accompanying consolidated balance sheet as of December 31, 2020 is as follows

The effect of the Restatement described above on the accompanying consolidated balance sheet as of December 31, 2020 is as follows:

 

                                       
   Consolidated Balance Sheet as at December 31, 2020 
   As Previously
Reported
   Inventory Costing
Errors
   Loss Contract
Reserve
   Additional
Inventory Reserve
   As Restated 
ASSETS                    
Current Assets:                         
Cash  $6,033,537   $   $   $   $6,033,537 
Accounts receivable, net   4,962,906                   4,962,906 
Contract assets   19,729,638                   19,729,638 
Inventory   9,567,921    (1,875,950)        (1,305,683)   6,386,288 
Refundable income taxes   40,000                   40,000 
Prepaid expenses and other current assets   534,857                   534,857 
                          
Total Current Assets   40,868,859    (1,875,950)       (1,305,683)   37,687,226 
                          
Operating lease right-of-use assets   4,075,048                   4,075,048 
Property and equipment, net   2,521,742                   2,521,742 
Intangibles, net   250,000                   250,000 
Goodwill   1,784,254                   1,784,254 
Other assets   191,179                   191,179 
                          
Total Assets  $49,691,082   $(1,875,950)  $   $(1,305,683)  $46,509,449 
                          
Liabilities and Shareholders’ Deficit                         
Current Liabilities:                         
Accounts payable  $12,092,684   $   $   $   $12,092,684 
Accrued expenses   5,693,518    244,403              5,937,921 
Contract liabilities   1,650,549                   1,650,549 
Loss reserve   800,971         1,208,276         2,009,247 
Current portion of long-term debt   6,501,666                   6,501,666 
Operating lease liabilities   1,819,237                   1,819,237 
Income taxes payable   862    86              948 
                          
Total Current Liabilities   28,559,487    244,489    1,208,276        30,012,252 
                          
Line of credit   20,738,685                   20,738,685 
Long-term operating lease liabilities   2,537,149                   2,537,149 
Long-term debt, net of current portion   6,205,095                   6,205,095 
                          
Total Liabilities   58,040,416    244,489    1,208,276        59,493,181 
                          
Shareholders’ Deficit:                         
Common stock   11,951                   11,951 
Additional paid-in capital   72,005,841                   72,005,841 
Accumulated deficit   (80,367,126)   (2,120,439)   (1,208,276)   (1,305,683)   (85,001,524)
Total Shareholders Deficit   (8,349,334)   (2,120,439)   (1,208,276)   (1,305,683)   (12,983,732)
Total Liabilities and Shareholders Deficit  $49,691,082   $(1,875,950)  $   $(1,305,683)  $46,509,449 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three and nine months ended September 30, 2020 is as follows:

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three and nine months ended September 30, 2020 is as follows:

                     
   Consolidated Statement of Operation For the three months ended September 30, 2020 (Unaudited) 
     
   As Previously
Reported
   Inventory
Costing Errors
   Loss Contract
Reserve
   Inventory Reserve   As Restated 
Revenue   $25,576,718   $   $   $   $25,576,718 
Cost of sales    21,394,243    112,446    (206,159)   69,157    21,369,687 
Gross profit    4,182,475    (112,446)   206,159    (69,157)   4,207,031 
Selling, general and administrative expenses    3,050,644                   3,050,644 
Profit from operations    1,131,831    (112,446)   206,159    (69,157)   1,156,387 
                          
Other expense:                         
Interest expense    (309,008)                  (309,008)
Income before provision for income taxes    822,823    (112,446)   206,159    (69,157)   847,379 
                          
Provision for income taxes    7,614                7,614 
Net Income   $815,209   $(112,446)  $206,159   $(69,157)  $839,765 
Income per common share - basic   $0.07   $(0.01)  $0.02   $(0.01)  $0.07 
Income per common share - diluted   $0.07   $(0.01)  $0.02   $(0.01)  $0.07 
Basic    11,894,469                11,894,469 
Diluted    11,894,469                11,917,149 

                               
                                       
   Consolidated Statement of Operation For the nine months ended September 30, 2020 (Unaudited) 
     
   As Previously Reported   Inventory
Costing Errors
   Loss Contract
Reserve
   Inventory Reserve   As Restated 
Revenue   $62,175,872   $   $   $   $62,175,872 
Cost of sales    54,715,508    938,689    (6,753)   352,074    55,999,518 
Gross profit    7,460,364    (938,689)   6,753    (352,074)   6,176,354 
Selling, general and administrative expenses    8,958,986                   8,958,986 
Loss from operations    (1,498,622)   (938,689)   6,753    (352,074)   (2,782,632)
                          
Other expense:                         
Interest expense    (1,085,805)                  (1,085,805)
Loss before provision for income taxes    (2,584,427)   (938,689)   6,753    (352,074)   (3,868,437)
                          
Provision for income taxes    9,714                9,714 
Net loss   $(2,594,141)  $(938,689)  $6,753   $(352,074)  $(3,878,151)
Loss per common share - basic   $(0.22)  $(0.08)  $0.00   $(0.03)  $(0.33)
Loss per common share - diluted   $(0.22)  $(0.08)  $0.00   $(0.03)   (0.33)
Basic    11,862,506                11,862,506 
Diluted    11,862,506                11,862,506 

The following table presents the impact of the Restatement on the Company’s shareholders’ deficit as of December 31, 2019 (as restated), March 31, 2020 (as restated), June 30, 2020 (as restated), September 30, 2020 (as restated) and December 31, 2020 (as restated):

The following table presents the impact of the Restatement on the Company’s shareholders’ deficit as of December 31, 2019 (as restated), March 31, 2020 (as restated), June 30, 2020 (as restated), September 30, 2020 (as restated) and December 31, 2020 (as restated):

 

                     
   Common Stock Shares   Common Stock   Additional Paid-in Capital   Accumulated Deficit   Total Shareholders’ Deficit 
Balance, December 31, 2019
(As Restated)
   11,818,830   $11,819   $71,294,629   $(81,346,771)  $(10,040,323)
Net Loss (as previously reported)                 $(2,812,519)  $(2,812,519)
Inventory Costing Errors               (315,999)   (315,999)
Loss Contract Reserve               (9,371)   (9,371)
Inventory Reserve               (219,466)   (219,466)
Cumulative restatement adjustments               (544,836)   (544,836)
Net Loss (as restated)                  (3,357,355)   (3,357,355)
Stock-based compensation   18,388    18    347,167        347,185 
Balance, March 31, 2020
(As Restated)
   11,837,218   $11,837   $71,641,796   $(84,704,126)  $(13,050,493)
Net Loss (as previously reported)                 $(596,831)  $(596,831)
Inventory Costing Errors               (510,244)   (510,244)
Loss Contract Reserve               (190,035)   (190,035)
Inventory Reserve               (63,451)   (63,451)
Cumulative restatement adjustments               (763,730)   (763,730)
Net Loss (as restated)                  (1,360,561)   (1,360,561)
Stock-based compensation   18,388    19    189,184        189,203 
Balance, June 30, 2020
(As Restated)
   11,855,606   $11,856   $71,830,980   $(86,064,687)  $(14,221,851)
Net Income (as previously reported)                 $815,209   $815,209 
Inventory Costing Errors               (112,446)   (112,446)
Loss Contract Reserve               206,159    206,159 
Inventory Reserve               (69,157)   (69,157)
Cumulative restatement adjustments               24,556    24,556 
Net Income (as restated)                  839,765    839,765 
Stock-based compensation   70,571    70    141,031        141,101 
Balance, September 30, 2020
(As Restated)
   11,926,177   $11,926   $71,972,011   $(85,224,922)  $(13,240,985)
Net Income             $1,273,703   $1,273,703 
Inventory Costing Errors               (1,071,395)   (1,071,395)
Loss Contract Reserve               99,921    99,921 
Inventory Reserve               (78,831)   (78,831)
Cumulative restatement adjustments               (1,050,305)   (1,050,305)
Net Income (as restated)                  223,398    223,398 
Stock-based compensation   25,094    25    33,830        33,855 
Balance, December 31, 2020
(As Restated)
   11,951,271   $11,951   $72,005,841   $(85,001,524)  $(12,983,732)

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the nine months ended September 30, 2020 is as follows:

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the nine months ended September 30, 2020 is as follows:

                       
   Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 (Unaudited) 
   As Previously Reported   Inventory Costing Errors   Loss Contract Reserve   Inventory Reserve   As Restated 
Cash flows from operating activities:                         
Net Loss   $(2,594,141)  $(938,689)  $6,753   $(352,074)  $(3,878,151)
Adjustments to reconcile net loss to net cash used in operating activities:                         
Depreciation and amortization    769,690                   769,690 
Amortization of debt issuance cost    80,764                   80,764 
Cash expended in excess of rent expense    (115,932)                  (115,932)
Stock-based compensation expense    677,489                   677,489 
Bad debt expense    (47,410)               (47,410)
Changes in operating assets and liabilities:                         
Increase in accounts receivable    (232,310)                  (232,310)
Increase in contract assets    (3,128,460)                  (3,128,460)
Increase in inventory    (2,850,707)   852,222         352,074    (1,646,411)
Decrease in prepaid expenses and other current assets    121,075                   121,075 
Decrease in refundable income taxes    439,445                439,445 
Increase in accounts payable and accrued expenses    5,770,902    86,467              5,857,369 
Decrease in contract liabilities    (1,092,266)                  (1,092,266)
Decrease in loss reserve    (1,081,516)        (6,753)        (1,088,269)
Net cash used in operating activities    (3,283,377)               (3,283,377)
Cash flows from investing activities:                         
Purchase of property and equipment    (11,888)               (11,888)
Net cash used in investing activities    (11,888)               (11,888)
Cash flows from financing activities:                         
Proceeds from PPP loan    4,795,000                   4,795,000 
Payments on long-term debt    (1,855,209)                  (1,855,209)
Debt issuance costs    (107,540)               (107,540)
Net cash provided by financing activities    2,832,251                2,832,251 
Net decrease in cash and restricted cash    (463,014)                  (463,014)
Cash and restricted cash at beginning of year    5,432,793                5,432,793 
Cash and restricted cash at end of year   $4,969,779   $   $   $   $4,969,779 
Supplemental schedule of cash flow information:                         
Cash paid during the year for interest   $1,156,126   $   $   $   $1,156,126 
Cash (received) from income taxes   $(449,749)  $   $   $   $(449,749)